University of Utah Wins $16M for Molecular and Translational Science Center | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Utah Department of Medicine has been awarded $16 million from the National Heart, Lung, and Blood Institute to fund interdisciplinary studies that delve into the molecular and cellular causes of blood clots.

The funding will support the University's Molecular Medicine Translational Research Center in Thrombosis, which will use the funding for basic and clinical science efforts to discover and test new diagnostic, preventative, and therapeutic interventions for thrombosis, the university said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.